ETRM - Canaccord Price Target $6
Analysts at Canaccord Genuity raised their price target on shares of EnteroMedics (NASDAQ:ETRM) from $3.00 to $6.00 in a research report issued to clients and investors on Friday, StockRatingsNetwork.com reports. Canaccord Genuity’s price target would indicate a potential upside of 161.89% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Craig Hallum raised their price target on shares of EnteroMedics to $6.00 in a research note on Monday, January 6th.
Separately, analysts at Roth Capital raised their price target on shares of EnteroMedics from $2.00 to $3.00 in a research note on Wednesday, December 4th. Finally, analysts at Northland Securities raised their price target on shares of EnteroMedics from $3.00 to $7.00 in a research note on Tuesday, December 3rd. They now have an “average” rating on the stock. One research analyst has rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $5.33.
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
